Publications Office of the EU
Czech Republic-Hradec Králové: Antineoplastic agents - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Czech Republic-Hradec Králové: Antineoplastic agents

  • Published
    28/06/2017
  • Deadline
    28/08/2017
  • Awarded
    21/12/2017
  • Today
    07/10/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Fakultní nemocnice Hradec Králové
Place of performance
NUTS code: CZ052 Královéhradecký kraj
Location of buyer
NUTS code: CZ052 Královéhradecký kraj
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
68,026,585.00 CZK
Total final contract value (excluding VAT)
94,076,409.72 CZK
Number of lots
2
Tender reference number
Not available
Description

Předmětem zakázky jsou průběžné dodávky léčivých přípravků s obsahem ipilimumabu a nivolumabu po dobu 3 let dle aktuálních potřeb zadavatele.

Submission Method
Tenders or requests to participate must be submitted to:
Official name: Fakultní nemocnice Hradec Králové
National registration number: 00179906
Postal address: Sokolská 581
Town: Hradec Králové-Nový Hradec Králové
NUTS code: CZ052
Postal code: 500 05
Country: CZE
Contact person: Petra Šmákalová
Main address: https://www.fnhk.cz
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Check linked documents for details
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.